{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:34:37Z","timestamp":1793406877991,"version":"4.5.0"},"reference-count":47,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,14]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) affects around 10% of the global population and has been estimated to affect around 50% of individuals with type 2 diabetes and 50% of those with heart failure. The guideline-recommended approach is to manage with disease-modifying therapies, but real-world data suggest that prescribing rates do not reflect this in practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop a cross-specialty consensus on optimal management of the patient with CKD using a modified Delphi method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>An international steering group of experts specialising in internal medicine, endocrinology\/diabetology, nephrology and primary care medicine developed 42 statements on aspects of CKD management including identification and screening, risk factors, holistic management, guidelines, cross-specialty alignment and education. Consensus was determined by agreement using an online survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>The survey was distributed to cardiologists, nephrologists, endocrinologists and primary care physicians across 11 countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcomes and measures<\/jats:title>\n                    <jats:p>The threshold for consensus agreement was established a priori by the steering group at 75%. Stopping criteria were defined as a target of 25 responses from each country (N=275), and a 4-week survey period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>274 responses were received in December 2022, 25 responses from Argentina, Australia, Brazil, Guatemala, Mexico, Singapore, South Korea, Taiwan, Thailand, Turkey and 24 responses from Egypt. 53 responses were received from cardiologists, 52 from nephrologists, 55 from endocrinologists and 114 from primary care physicians. 37 statements attained very high agreement (\u226590%) and 5 attained high agreement (\u226575%\u2009and &lt;90%). Strong alignment between roles was seen across the statements, and different levels of experience (2\u20135 years or 5+ years), some variation was observed between countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is a high degree of consensus regarding aspects of CKD management among healthcare professionals from 11 countries. Based on these strong levels of agreement, the steering group derived 12 key recommendations focused on diagnosis and management of CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-080891","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T05:36:25Z","timestamp":1709789785000},"page":"e080891","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-7896","authenticated-orcid":false,"given":"Mustafa","family":"Arici","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Hacettepe Universitesi, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Helmy","family":"Assaad-Khalil","sequence":"additional","affiliation":[{"name":"Unit of Diabetes, Lipidology & Metabolism, Alexandria University Faculty of Medicine, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello Casaccia","family":"Bertoluci","sequence":"additional","affiliation":[{"name":"Endocrinology Division, Hospital de Cl\u00ednicas de Porto Alegre, Universidade Federal do Rio Grande do Sul Instituto de Biociencias, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Choo","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Jiunn","family":"Lee","sequence":"additional","affiliation":[{"name":"Lee\u2019s Clinic, Taiwan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Madero","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, National Heart Institute of Mexico, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Javier","family":"Rosa Diez","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"S\u00e1nchez Polo","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda y Trasplante Renal, Instituto Guatemalteco de Seguridad Social, Guatemala City, Guatemala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjin","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Catholic University of Korea College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerawat","family":"Thanachayanont","sequence":"additional","affiliation":[{"name":"Nephrology, Bhumirajanagarindra Kidney Institute, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Pollock","sequence":"additional","affiliation":[{"name":"Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"2025121600323098000_14.3.e080891.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"2025121600323098000_14.3.e080891.2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18169","article-title":"Clinical characteristics of and risk factors for chronic kidney disease among adults and children: an analysis of the CURE-CKD Registry","volume":"2","author":"Tuttle","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025121600323098000_14.3.e080891.3","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14829"},{"key":"2025121600323098000_14.3.e080891.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.173"},{"key":"2025121600323098000_14.3.e080891.5","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.01108","article-title":"Chronic kidney disease as a risk factor for heart failure with preserved ejection fraction: A focus on Microcirculatory factors and therapeutic targets","volume":"10","author":"van de Wouw","year":"2019","journal-title":"Front Physiol"},{"key":"2025121600323098000_14.3.e080891.6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.puhe.2016.02.029","article-title":"Hidden prevalence of chronic kidney disease in hypertensive patients: the strategic role of primary health care","volume":"140","author":"da Silva","year":"2016","journal-title":"Public Health"},{"key":"2025121600323098000_14.3.e080891.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"2025121600323098000_14.3.e080891.8","doi-asserted-by":"publisher","DOI":"10.1590\/S0101-28002011000100013"},{"key":"2025121600323098000_14.3.e080891.9","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"2025121600323098000_14.3.e080891.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2102953\/SUPPL_FILE\/NEJMOA2102953_DISCLOSURES.PDF"},{"key":"2025121600323098000_14.3.e080891.11","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.ekir.2022.05.033","article-title":"Low adherence to kidney disease: improving global outcomes 2012 CKD clinical practice guidelines despite clear evidence of utility","volume":"7","author":"James","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2025121600323098000_14.3.e080891.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.11.003"},{"key":"2025121600323098000_14.3.e080891.13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/IJNRD.S363133","article-title":"Chronic kidney disease management in the Middle East and Africa: concerns","volume":"16","author":"Al-Ghamdi","year":"2023","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"2025121600323098000_14.3.e080891.14","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9176026","article-title":"Active-controlled clinical trial to investigate the efficacy and safety of NW low-glu\u00ae in patients newly diagnosed with type 2 diabetes mellitus","volume":"2022","author":"Assaad-Khalil","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"2025121600323098000_14.3.e080891.15","doi-asserted-by":"crossref","unstructured":"Bertoluci MC , Silva J\u00fanior WS , Valente F , et al . UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes. Diabetol Metab Syndr 2023;15. doi:10.1186\/s13098-023-01121-x","DOI":"10.1186\/s13098-023-01121-x"},{"key":"2025121600323098000_14.3.e080891.16","doi-asserted-by":"crossref","DOI":"10.3390\/nu15183892","article-title":"Association of possible Sarcopenia or Sarcopenia with body composition, nutritional intakes, serum vitamin D levels, and physical activity among patients with type 2 diabetes mellitus in Taiwan","volume":"15","author":"Hsu","year":"2023","journal-title":"Nutrients"},{"key":"2025121600323098000_14.3.e080891.17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000534823","article-title":"Neurocognitive function with conventional Hemodialysis versus post-dilution Hemofiltration as initial treatment in ESKD patients. A randomized controlled trial. The DA-VINCI study","volume":"53","author":"Jimenez","year":"2024","journal-title":"Blood Purif"},{"key":"2025121600323098000_14.3.e080891.18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41581-023-00796-9","article-title":"Targeted identification of risk and treatment of diabetic kidney disease","volume":"20","author":"Glastras","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2025121600323098000_14.3.e080891.19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s40620-023-01590-3","article-title":"Relationship between Lipoprotein(A) levels, cardiovascular outcomes and death in patients with chronic kidney disease: a systematic review of prospective studies","volume":"36","author":"Barbagelata","year":"2023","journal-title":"J Nephrol"},{"key":"2025121600323098000_14.3.e080891.20","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2023.1764"},{"key":"2025121600323098000_14.3.e080891.21","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9713045","article-title":"Correlation of the dietary protein intake between those estimated from a short protein food-recall questionnaire and from 24-hour urinary urea-nitrogen excretion in stages 3-4 chronic kidney disease patients","volume":"2023","author":"Thanachayanont","year":"2023","journal-title":"Int J Nephrol"},{"key":"2025121600323098000_14.3.e080891.22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/ejhf.2612","article-title":"An international Delphi consensus regarding best practice recommendations for Hyperkalaemia across the Cardiorenal spectrum","volume":"24","author":"Burton","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025121600323098000_14.3.e080891.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.12.002"},{"key":"2025121600323098000_14.3.e080891.24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5414\/CNWKDEditorial","article-title":"Kidney health for everyone everywhere - from prevention to detection and equitable access to care","volume":"93","author":"Li","year":"2020","journal-title":"Clin Nephrol"},{"key":"2025121600323098000_14.3.e080891.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.12.012"},{"key":"2025121600323098000_14.3.e080891.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.10.012"},{"key":"2025121600323098000_14.3.e080891.27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7861\/fhj.2022-0020","article-title":"Development of minimal resource pre-screening tools for chronic kidney disease in people with type 2 diabetes","volume":"9","author":"Sammut-Powell","year":"2022","journal-title":"Future Healthc J"},{"key":"2025121600323098000_14.3.e080891.28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","article-title":"Acute kidney injury","volume":"7","author":"Kellum","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025121600323098000_14.3.e080891.29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nefro.2021.06.007","article-title":"Acute kidney injury and risk of cardiovascular outcomes: A nationwide cohort study","volume":"42","author":"Schytz","year":"2022","journal-title":"Nefrolog\u00eda"},{"key":"2025121600323098000_14.3.e080891.30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007682","article-title":"Cardiometabolic center of excellence: A novel care delivery model for secondary prevention of cardiovascular disease in type 2 diabetes","volume":"14","author":"Thomas","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025121600323098000_14.3.e080891.31","first-page":"iii104","article-title":"Towards rational approaches of health care utilization in complex patients: an exploratory randomized trial comparing a novel combined clinic to multiple specialty clinics in patients with renal disease-cardiovascular disease-diabetes","volume":"27 Suppl 3","author":"Weber","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2025121600323098000_14.3.e080891.32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4997\/jrcpe.2017.118","article-title":"Novel combined management approaches to patients with diabetes, chronic kidney disease and cardiovascular disease","volume":"47","author":"Spaak","year":"2017","journal-title":"J R Coll Physicians Edinb"},{"key":"2025121600323098000_14.3.e080891.33","unstructured":"International Society of Nephrology . ISN-Global Kidney Health Atlas 3rd Edition. 2023."},{"key":"2025121600323098000_14.3.e080891.34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019121308"},{"key":"2025121600323098000_14.3.e080891.35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101751","article-title":"Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study","volume":"55","author":"Yang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025121600323098000_14.3.e080891.36","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020050682"},{"key":"2025121600323098000_14.3.e080891.37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamainternmed.2020.0193","article-title":"Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate","volume":"180","author":"Qiao","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2025121600323098000_14.3.e080891.38","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314158"},{"key":"2025121600323098000_14.3.e080891.39","doi-asserted-by":"crossref","unstructured":"Morales E , Cravedi P , Manrique J . n.d. Management of chronic Hyperkalemia in patients with chronic kidney disease: an old problem with news options. Front Med;8. doi:10.3389\/fmed.2021.653634","DOI":"10.3389\/fmed.2021.653634"},{"key":"2025121600323098000_14.3.e080891.40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5049\/EBP.2019.17.1.1","article-title":"Pharmacologic treatment of chronic Hyperkalemia in patients with chronic kidney disease","volume":"17","author":"Kim","year":"2019","journal-title":"Electrolyte Blood Press"},{"key":"2025121600323098000_14.3.e080891.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.09.018"},{"issue":"Suppl 3","key":"2025121600323098000_14.3.e080891.42","doi-asserted-by":"crossref","first-page":"iii36","DOI":"10.1093\/ndt\/gfz225","article-title":"Optimally managing Hyperkalemia in patients with Cardiorenal syndrome","volume":"34","author":"Wang","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2025121600323098000_14.3.e080891.43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10741-020-10069-3","article-title":"Management of Raasi-associated Hyperkalemia in patients with cardiovascular disease","volume":"26","author":"Silva-Cardoso","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"11 Suppl","key":"2025121600323098000_14.3.e080891.44","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"2025121600323098000_14.3.e080891.45","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ejhf.1199","article-title":"Incidence, predictors, and clinical management of Hyperkalaemia in New users of Mineralocorticoid receptor antagonists","volume":"20","author":"Trevisan","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025121600323098000_14.3.e080891.46","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0189-z","article-title":"The burden of Comorbidity in people with chronic kidney disease stage 3: a cohort study","volume":"16","author":"Fraser","year":"2015","journal-title":"BMC Nephrol"},{"key":"2025121600323098000_14.3.e080891.47","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120493","article-title":"The number of comorbidities predicts renal outcomes in patients with stage 3\u207b5 chronic kidney disease","volume":"7","author":"Lee","year":"2018","journal-title":"J Clin Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-080891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:32:42Z","timestamp":1765873962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-080891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-080891"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-080891","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}